The translational medicine-focused research services provider, which counts Renfu Pharmaceutical as an investor, has completed a Humanwell-backed round sized at about $56m.

Chishima Real Estate and Miraca helped add $6.8m to extend Kringle‘s latest round to $15.5m which will fund development of its rare disease treatments.

The internet company’s investment arm has earmarked just over $32m to support portfolio companies through the Novel Coronavirus Recession Prevention Program.

Although the pandemic will represent a damaging shock, Watanabe believes it may eventually be beneficial for Japan's startup space.

DeHaat will use the proceeds from the AgFunder-backed round to expand its retail network and bolster its big data and AI technology.

Lepu Medical and Shandong Buchang Pharma were among the limited partners that have backed the healthcare investor's latest fund.

Tencent and founding investor PLDT helped digital financial technology provider Voyager Innovations raise the first part of a new round.

AI-as-a-service provider Intellifusion attracted Tsinghua University’s investment arm for a round that will fund product development and marketing.

SAIC Motor fund Hengxu Investment and a Sinopharm-backed joint venture were among the investors in a $66.3m round for the RNA drug developer.

Lilly Asia Ventures and Johnson & Johnson Innovation – JJDC are both investing in a series A round for the cell therapy developer, a spinoff from Genscript Biotech.